Indexové číslo
|
Chemický název
|
Číslo ES
|
Číslo CAS
|
Klasifikace
|
Označení
|
Specifické koncent. limity, multiplikační faktory a ATE
|
Poznámky
|
Kódy tříd a kategorií nebezpečnosti
|
Kódy standardních vět o nebezpečnosti
|
Kódy výstražných symbolů a signálních slov
|
Kódy standardních vět o nebezpečnosti
|
Kódy doplň. standardních vět o nebezpečnosti
|
„005-007-00-2
|
kyselina boritá [1]
kyselina boritá [2]
|
233-139-2 [1]
234-343-4 [2]
|
10043-35-3 [1]
11113-50-1 [2]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
„005-008-00-8
|
oxid boritý
|
215-125-8
|
1303-86-2
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
„005-011-00-4
|
tetraboritan disodný, monohydrát; [1]
tetraboritan disodný, bezvodý; [2]
sodná sůl kyseliny orthoborité [3]
tetraboritan disodný, dekahydrát [4]
tetraboritan disodný pentahydrát [5]
|
235-541-3 [1]
215-540-4 [2]
237-560-2 [3]
215-540-4 [4]
215-540-4 [5]
|
12267-73-1 [1]
1330-43-4 [2]
13840-56-7 [3]
1303-96-4 [4]
12179-04-3 [5]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
„006-069-00-3
|
thiofanát-methyl (ISO);
dimethyl (1,2-fenylendikarbamothioyl)dikarbamát;
dimethyl 4,4′-(o-fenylen)bis(3-thioallofanát)
|
245-740-7
|
23564-05-8
|
Carc. 2
Muta. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H341
H332
H317
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H351
H341
H332
H317
H410
|
|
inhalační: ATE = 1,7 mg/l
(prach nebo mlha)
M = 10
M = 10“
|
|
„006-076-00-1
|
mankozeb (ISO); N,N’-ethylenbis(dithiokarbamát) manganatý, polymerní komplex se zinečnatou solí
|
-
|
8018-01-7
|
Carc. 2
Repr. 1B
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H360D
H373 (štítná žláza, nervový systém)
H317
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H351
H360D
H373 (štítná žláza, nervový systém)
H317
H410
|
|
M = 10
M = 10“
|
|
„015-113-00-0
|
tolklofos-methyl (ISO);
O-(2,6-dichlor-p-tolyl) O,O-dimethylthiofosfát
|
260-515-3
|
57018-04-9
|
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
H317
H400
H410
|
GHS07
GHS09
Wng
|
H317
H410
|
|
M = 1
M = 1“
|
|
„028-007-00-4
|
disulfid triniklu;
subsulfid nikelnatý; [1]
heazlewoodit [2]
|
234-829-6 [1]
- [2]
|
12035-72-2 [1]
12035-71-1 [2]
|
Carc. 1 A
Muta. 2
Acute Tox. 3
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H350i
H341
H331
H372**
H317
H400
H410
|
GHS08
GHS06
GHS09
Dgr
|
H350i
H341
H331
H372**
H317
H410
|
|
inhalační:
ATE = 0,92 mg/l
(prach nebo mlha)“
|
|
„029-002-00-X
|
oxid měďný
|
215-270-7
|
1317-39-1
|
Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H302
H318
H410
|
|
inhalační: ATE = 3,34 mg/l (prach nebo mlha)
orální: ATE = 500 mg/kg TH
M = 100
M = 10“
|
|
„029-015-00-0
|
thiokyanatan měďný
|
214-183-1
|
1111-67-7
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
EUH032
|
M = 10
M = 10“
|
|
„029-016-00-6
|
oxid měďnatý
|
215-269-1
|
1317-38-0
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 100
M = 10“
|
|
„029-017-00-1
|
chlorid-trihydroxid diměďnatý
|
215-572-9
|
1332-65-6
|
Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H332
H301
H410
|
|
inhalační: ATE = 2,83 mg/l (prach nebo mlha)
orální: ATE = 299 mg/kg TH
M = 10
M = 10“
|
|
„029-018-00-7
|
hexahydroxid-síran tetraměďnatý; [1]
hexahydroxid-síran tetraměďnatý hydrát [2]
|
215-582-3 [1]
215-582-3 [2]
|
1333-22-8 [1]
12527-76-3 [2]
|
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H400
H410
|
GHS07
GHS09
Wng
|
H302
H410
|
|
orální: ATE = 500 mg/kg TH
M = 10
M = 10“
|
|
„029-019-01-X
|
měděné vločky (potažené alifatickou kyselinou)
|
-
|
-
|
Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H302
H319
H400
H410
|
GHS06
GHS09
Dgr
|
H331
H302
H319
H410
|
|
inhalační: ATE = 0,733 mg/l (prach nebo mlha)
orální: ATE = 500 mg/kg TH
M = 10
M = 10“
|
|
„029-020-00-8
|
uhličitan měďnatý – hydroxid měďnatý (1:1)
|
235-113-6
|
12069-69-1
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H319
H400
H410
|
GHS07
GHS09
Wng
|
H332
H302
H319
H410
|
|
inhalační: ATE = 1,2 mg/l (prach nebo mlha)
orální: ATE = 500 mg/kg TH
M = 10
M = 10“
|
|
„029-021-00-3
|
hydroxid měďnatý
|
243-815-9
|
20427-59-2
|
Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H330
H302
H318
H400
H410
|
GHS06
GHS05
GHS09
Dgr
|
H330
H302
H318
H410
|
|
inhalační: ATE = 0,47 mg/l (prach nebo mlha)
orální: ATE = 500 mg/kg TH
M = 10
M = 10“
|
|
„029-022-00-9
|
bordeauxská jícha;
reakční produkty síranu měďnatého a hydroxidu vápenatého
|
-
|
8011-63-0
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H318
H410
|
|
inhalační: ATE = 1,97 mg/l (prach nebo mlha)
M = 10
M = 1“
|
|
„029-023-00-4
|
síran měďnatý, pentahydrát
|
231-847-6
|
7758-99-8
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
orální: ATE = 481 mg/kg TH
M = 10
M = 1“
|
|
„601-029-00-7
|
dipenten;
limonen [1]
(S)-p-mentha-1,8-dien; l-limonen [2]
trans-1-methyl-4-(1-methylvinyl)cyklohexen; [3]
(±)-1-methyl-4-(1-methylvinyl)cyklohexen [4]
|
205-341-0 [1]
227-815-6 [2]
229-977-3 [3]
231-732-0 [4]
|
138-86-3 [1]
5989-54-8 [2]
6876-12-6 [3]
7705-14-8 [4]
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H226
H315
H317
H400
H410
|
GHS02
GHS07
GHS09
Wng
|
H226
H315
H317
H410
|
|
|
C“
|
„601-096-00-2
|
(R)-p-mentha-1,8-dien;
d-limonen
|
227-813-5
|
5989-27-5
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1B
Asp. Tox. 1
Aquatic Acute 1
Aquatic Chronic 3
|
H226
H315
H317
H304
H400
H412
|
GHS02
GHS07
GHS08
GHS09
Dgr
|
H226
H315
H317
H304
H410
|
|
M = 1“
|
|
„603-024-00-5
|
1,4-dioxan
|
204-661-8
|
123-91-1
|
Flam. Liq. 2
Carc. 1B
STOT SE 3
Eye Irrit. 2
|
H225
H350
H335
H319
|
GHS02
GHS08
GHS07
Dgr
|
H225
H350
H335
H319
|
EUH019
EUH066
|
|
D“
|
„603-066-00-4
|
7-oxa-3-oxiranylbicyklo[4.1.0]heptan; 1,2-epoxy-4-(1,2-epoxyethyl)cyklohexan 4-vinylcyklohexendiepoxid
|
203-437-7
|
106-87-6
|
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3
Acute Tox. 4
|
H350
H341
H360F
H331
H302
|
GHS08
GHS06
Dgr
|
H350
H341
H360F
H331
H302
|
|
inhalační: ATE = 0,5 mg/l (prach nebo mlha)
oral: ATE = 1 847 mg/kg TH“
|
|
„603-098-00-9
|
2-fenoxyethan-1-ol
|
204-589-7
|
122-99-6
|
Acute Tox. 4
STOT SE 3
Eye Dam. 1
|
H302
H335
H318
|
GHS05
GHS07
Dgr
|
H302
H335
H318
|
|
orální:
ATE = 1 394 mg/kg TH“
|
|
„606-004-00-4
|
4-methylpentan-2-on; isobutyl(methyl)keton
|
203-550-1
|
108-10-1
|
Flam. Liq. 2
Carc. 2
Acute Tox. 4
STOT SE 3
Eye Irrit. 2
|
H225
H351
H332
H336
H319
|
GHS02
GHS07
GHS08
Dgr
|
H225
H351
H332
H336
H319
|
EUH066
|
inhalační: ATE = 11 mg/l (páry)“
|
|
„607-421-00-4
|
cypermethrin (ISO);
α-kyan-3-fenoxybenzyl 3-(2,2-dichlorvinyl)-2,2-dimethylcyklopropankarboxylát; cypermethrin cis/trans +/- 40/60
|
257-842-9
|
52315-07-8
|
Acute Tox. 4
Acute Tox. 4
STOT SE 3
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H335
H373 (nervový systém)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H332
H302
H335
H373 (nervový systém)
H410
|
|
orální; ATE = 500 mg/kg TH
inhalační; ATE = 3,3 mg/l (prach nebo mlha)
M = 100000
M = 100000“
|
|
„607-424-00-0
|
trifloxystrobin (ISO); methyl-(E)-α-(methoxyimino)-2-{[(E)-({1-[3-(trifluormethyl)fenyl]ethyliden}amino)oxy]methyl}benzen-1-acetát
|
-
|
141517-21-7
|
Lact.
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H362
H317
H400
H410
|
GHS07
GHS09
Wng
|
H362
H317
H410
|
|
M = 100
M = 10“
|
|
„607-434-00-5
|
mekoprop-P (ISO) [1] a jeho soli;
(R)-2-(4-chlor-2-methylfenoxy)propanová kyselina [1] a její soli
|
240-539-0 [1]
|
16484-77-8 [1]
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
orální: ATE = 431 mg/kg TH
M = 10
M = 10“
|
|
„608-058-00-4
|
esfenvalerát (ISO);
[(S)-(3-fenoxyfenyl)kyanmethyl]-(S)-2-(4-chlorfenyl)-3-methylbutanoát
|
-
|
66230-04-4
|
Acute Tox. 3
Acute Tox. 3
STOT SE 1
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H301
H370 (nervový systém)
H373
H317
H400
H410
|
GHS06
GHS08
GHS09
Dgr
|
H331
H301
H370 (nervový systém)
H373
H317
H410
|
|
orální; ATE = 88,5 mg/kg TH
inhalační; ATE = 0,53 mg/l (prach nebo mlha)
M = 10 000
M = 10 000 “
|
|
„612-067-00-9
|
3-(aminomethyl)-3,5,5-trimethylcyklohexan-1-amin
|
220-666-8
|
2855-13-2
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1 A
|
H302
H314
H318
H317
|
GHS05
GHS07
Dgr
|
H302
H314
H317
|
|
orální: ATE = 1 030 mg/kg TH
Skin Sens. 1 A; H317: C ≥ 0,001 %“
|
|
„612-252-00-4
|
imidakloprid (ISO);
(E)-1-(6-chlor-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamin;
(2E)-1-[(6-chlorpyridin-3-yl) methyl]-N-nitroimidazolidin-2-imin
|
428-040-8
|
138261-41-3
|
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H301
H410
|
|
orální: ATE = 131 mg/kg TH
M = 100
M = 1 000 “
|
|
„613-048-00-8
|
karbendazim (ISO); methyl-N- (benzimidazol-2-yl)karbamát
|
234-232-0
|
10605-21-7
|
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H340
H360FD
H317
H400
H410
|
GHS07
GHS08
GHS09
Dgr
|
H340
H360FD
H317
H410
|
|
M = 10
M = 10“
|
|
„613-102-00-0
|
dimethomorf (ISO); (E,Z)-4-(3-(4-chlorfenyl)-3-(3,4-dimethoxyfenyl)acryloyl)morfolin
|
404-200-2
|
110488-70-5
|
Repr. 1B
Aquatic Chronic 2
|
H360F
H411
|
GHS08
GHS09
Dgr
|
H360F
H411“
|
|
|
|
„613-111-00-X
|
1,2,4-triazol
|
206-022-9
|
288-88-0
|
Repr. 1B
Acute Tox. 4
Eye Irrit. 2
|
H360FD
H302
H319
|
GHS08
GHS07
Dgr
|
H360FD
H302
H319
|
|
orální: ATE = 1 320 mg/kg TH“
|
|
„613-166-00-X
|
flumioxazin (ISO);
7-fluor-4-(prop-2-yn-1-yl)-6-(3,4,5,6-tetrahydroftalimido)-1,4-benzoxazin-3(2H)-on
|
-
|
103361-09-7
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 1 000
M = 1 000 “
|
|
„613-208-00-7
|
imazamox (ISO);
(RS)-2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydroimidazol-2-yl)-5-(methoxymethyl)nikotinová kyselina
|
-
|
114311-32-9
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10“
|
|
„613-267-00-9
|
thiamethoxam (ISO);
N-nitro-{3-[(2-chlorthiazol-5-yl)methyl]-5-methyl-1,3,5-oxadiazinan-4-yliden}amin
|
428-650-4
|
153719-23-4
|
Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H361fd
H302
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H361fd
H302
H410
|
|
orální: ATE = 780 mg/kg TH
M = 10
M = 10“
|
|
„613-282-00-0
|
tritikonazol (ISO);
(1RS)-5-[(E)-4-chlorbenzyliden]-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyklopentan-1-ol
|
-
|
138182-18-0
|
Repr. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361f
H373
H400
H410
|
GHS08
GHS09
Wng
|
H361f
H373
H410
|
|
M = 1
M = 1“
|
|
„616-032-00-9
|
diflufenikan (ISO);
N-(2,4-difluorfenyl)-2-[3-(trifluormethyl)fenoxy]pyridin-3-karboxamid; 2′,4′-difluor-2-(α,α,α-trifluor-m-tolyloxy)nicotinanilid
|
-
|
83164-33-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10 000
M = 1 000 “
|
|
„616-106-00-0
|
fenmedifam (ISO); methyl-N-(3-{[N-(3-(methylfenyl)karbamoyl]oxy}fenyl)karbamát
|
237-199-0
|
13684-63-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10
M = 10“
|
|
„616-113-00-9
|
desmedipham (ISO);
ethyl-N-{3-[(N-fenylkarbamoyl)oxy]fenyl}karbamát
|
237-198-5
|
13684-56-5
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10“
|
|